ABK Biomedical Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
42
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$35M
- Investors
-
8
ABK Biomedical General Information
Description
Developer of a microsphere product designed to improve the treatment of hypervascular tumors. The company's product is a novel radiopaque bland embolic and beta radiation emitting agent that helps to improve the targeting of tumor vascularity and tumor tissue, enabling doctors to help standardize, optimize, and personalize minimally invasive therapies.
Contact Information
Website
www.abkbiomedical.comCorporate Office
- 155 Chain Lake Drive
- Unit 32
- Halifax, Nova Scotia B3S 1B3
- Canada
Corporate Office
- 155 Chain Lake Drive
- Unit 32
- Halifax, Nova Scotia B3S 1B3
- Canada
ABK Biomedical Timeline
ABK Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series D) | 09-May-2025 | $35M | Completed | Pre-Clinical Trials | ||
| 9. Later Stage VC (Series C) | 09-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 8. Secondary Transaction - Private | 01-Nov-2020 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC (Series B) | 08-Apr-2019 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC (Series A) | 18-Aug-2017 | Completed | Pre-Clinical Trials | |||
| 5. Seed Round | 23-Feb-2015 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 01-Jul-2014 | Completed | Startup | |||
| 3. Seed Round | 01-Oct-2012 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2012 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2012 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ABK Biomedical Comparisons
Industry
Financing
Details
ABK Biomedical Competitors (7)
One of ABK Biomedical’s 7 competitors is Recombinetics, a Venture Capital-Backed company based in New Brighton, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Recombinetics | Venture Capital-Backed | New Brighton, MN | ||||
| Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Carisma Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Alentis Therapeutics | Venture Capital-Backed | Allschwil, Switzerland | ||||
| Ekobi | Venture Capital-Backed | Edmonton, Canada |
ABK Biomedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ABK Biomedical Patents
ABK Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026081017-A1 | Delivery devices with dosage measurement | Pending | 16-Oct-2024 | ||
| WO-2025194261-A1 | Delivery device | Pending | 21-Mar-2024 | ||
| WO-2025194262-A1 | Valved container for dispensing radioactive microparticles | Pending | 21-Mar-2024 | ||
| US-20240002277-A1 | Radiopaque glass material | Pending | 01-Dec-2020 | ||
| WO-2022115940-A1 | Radiopaque glass material | Inactive | 01-Dec-2020 | C03C3/097 |
ABK Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ABK Biomedical Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| JPMorgan Life Sciences Private Capital | Venture Capital | Minority | ||
| Santé Ventures | Venture Capital | Minority | ||
| Eight Roads | Corporate Venture Capital | Minority | ||
| F-Prime | Venture Capital | Minority | ||
| PIC Investment Group | Family Office | Minority |
ABK Biomedical FAQs
-
When was ABK Biomedical founded?
ABK Biomedical was founded in 2012.
-
Where is ABK Biomedical headquartered?
ABK Biomedical is headquartered in Halifax, Canada.
-
What is the size of ABK Biomedical?
ABK Biomedical has 42 total employees.
-
What industry is ABK Biomedical in?
ABK Biomedical’s primary industry is Surgical Devices.
-
Is ABK Biomedical a private or public company?
ABK Biomedical is a Private company.
-
What is ABK Biomedical’s current revenue?
The current revenue for ABK Biomedical is .
-
How much funding has ABK Biomedical raised over time?
ABK Biomedical has raised $112M.
-
Who are ABK Biomedical’s investors?
JPMorgan Life Sciences Private Capital, Santé Ventures, Eight Roads, F-Prime, and PIC Investment Group are 5 of 8 investors who have invested in ABK Biomedical.
-
Who are ABK Biomedical’s competitors?
Recombinetics, Adaptimmune Therapeutics, Carisma Therapeutics, Alentis Therapeutics, and Ekobi are some of the 7 competitors of ABK Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
